Literature DB >> 34166081

Case Studies in Physiology: Temporal variations of the lung parenchyma and vasculature in asymptomatic COVID-19 pneumonia: a multispectral CT assessment.

Prashant Nagpal1, Amin Motahari1, Sarah E Gerard1, Junfeng Guo1,2, Joseph M Reinhardt2, Alejandro P Comellas3, Eric A Hoffman1,2,3, David W Kaczka1,2,4.   

Abstract

This study reports systematic longitudinal pathophysiology of lung parenchymal and vascular effects of asymptomatic COVID-19 pneumonia in a young, healthy never-smoking male. Inspiratory and expiratory noncontrast along with contrast dual-energy computed tomography (DECT) scans of the chest were performed at baseline on the day of acute COVID-19 diagnosis (day 0), and across a 90-day period. Despite normal vital signs and pulmonary function tests on the day of diagnosis, the CT scans and corresponding quantification metrics detected abnormalities in parenchymal expansion based on image registration, ground-glass (GGO) texture (inflammation) as well as DECT-derived pulmonary blood volume (PBV). Follow-up scans on day 30 showed improvement in the lung parenchymal mechanics as well as reduced GGO and improved PBV distribution. Improvements in lung PBV continued until day 90. However, the heterogeneity of parenchymal mechanics and texture-derived GGO increased on days 60 and 90. We highlight that even asymptomatic COVID-19 infection with unremarkable vital signs and pulmonary function tests can have measurable effects on lung parenchymal mechanics and vascular pathophysiology, which may follow apparently different clinical courses. For this asymptomatic subject, post COVID-19 regional mechanics demonstrated persistent increased heterogeneity concomitant with return of elevated GGOs, despite early improvements in vascular derangement.NEW & NOTEWORTHY We characterized the temporal changes of lung parenchyma and microvascular pathophysiology from COVID-19 infection in an asymptomatic young, healthy nonsmoking male using dual-energy CT. Lung parenchymal mechanics and microvascular disease followed different clinical courses. Heterogeneous perfused blood volume became more uniform on follow-up visits up to 90 days. However, post COVID-19 mechanical heterogeneity of the lung parenchyma increased after apparent improvements in vascular abnormalities, even with normal spirometric indices.

Entities:  

Keywords:  COVID-19; dual-energy computed tomography; longitudinal analysis; lung parenchyma; pulmonary vasculature

Mesh:

Year:  2021        PMID: 34166081      PMCID: PMC8384565          DOI: 10.1152/japplphysiol.00147.2021

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  37 in total

1.  Quantification of pulmonary emphysema from lung computed tomography images.

Authors:  R Uppaluri; T Mitsa; M Sonka; E A Hoffman; G McLennan
Journal:  Am J Respir Crit Care Med       Date:  1997-07       Impact factor: 21.405

2.  Computer recognition of regional lung disease patterns.

Authors:  R Uppaluri; E A Hoffman; M Sonka; P G Hartley; G W Hunninghake; G McLennan
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

3.  Comparison of low- and ultralow-dose computed tomography protocols for quantitative lung and airway assessment.

Authors:  Emily Hammond; Chelsea Sloan; John D Newell; Jered P Sieren; Melissa Saylor; Craig Vidal; Shayna Hogue; Frank De Stefano; Alexa Sieren; Eric A Hoffman; Jessica C Sieren
Journal:  Med Phys       Date:  2017-08-02       Impact factor: 4.071

4.  MDCT-based 3-D texture classification of emphysema and early smoking related lung pathologies.

Authors:  Ye Xu; Milan Sonka; Geoffrey McLennan; Junfeng Guo; Eric A Hoffman
Journal:  IEEE Trans Med Imaging       Date:  2006-04       Impact factor: 10.048

5.  Computer-aided classification of interstitial lung diseases via MDCT: 3D adaptive multiple feature method (3D AMFM).

Authors:  Ye Xu; Edwin J R van Beek; Yu Hwanjo; Junfeng Guo; Geoffrey McLennan; Eric A Hoffman
Journal:  Acad Radiol       Date:  2006-08       Impact factor: 3.173

6.  Total lung capacity by plethysmography and high-resolution computed tomography in COPD.

Authors:  Jamie L Garfield; Nathaniel Marchetti; John P Gaughan; Robert M Steiner; Gerard J Criner
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-02-22

7.  Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT.

Authors:  Min Lang; Avik Som; Dexter P Mendoza; Efren J Flores; Nicholas Reid; Denston Carey; Matthew D Li; Alison Witkin; Josanna M Rodriguez-Lopez; Jo-Anne O Shepard; Brent P Little
Journal:  Lancet Infect Dis       Date:  2020-04-30       Impact factor: 25.071

8.  CT image segmentation for inflamed and fibrotic lungs using a multi-resolution convolutional neural network.

Authors:  Sarah E Gerard; Jacob Herrmann; Yi Xin; Kevin T Martin; Emanuele Rezoagli; Davide Ippolito; Giacomo Bellani; Maurizio Cereda; Junfeng Guo; Eric A Hoffman; David W Kaczka; Joseph M Reinhardt
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.996

9.  Lung and kidney perfusion deficits diagnosed by dual-energy computed tomography in patients with COVID-19-related systemic microangiopathy.

Authors:  Ilkay S Idilman; Gulcin Telli Dizman; Selin Ardali Duzgun; Ilim Irmak; Musturay Karcaaltincaba; Ahmet Cagkan Inkaya; Figen Demirkazik; Gamze Durhan; Meltem Gulsun Akpinar; Orhan Macit Ariyurek; Erhan Akpinar; Jordi Rello; Murat Akova; Deniz Akata
Journal:  Eur Radiol       Date:  2020-08-29       Impact factor: 5.315

10.  Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China.

Authors:  Yueying Pan; Hanxiong Guan; Shuchang Zhou; Yujin Wang; Qian Li; Tingting Zhu; Qiongjie Hu; Liming Xia
Journal:  Eur Radiol       Date:  2020-02-13       Impact factor: 7.034

View more
  2 in total

Review 1.  Origins of and lessons from quantitative functional X-ray computed tomography of the lung.

Authors:  Eric A Hoffman
Journal:  Br J Radiol       Date:  2022-03-01       Impact factor: 3.629

Review 2.  Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates.

Authors:  Marieke A Stammes; Ji Hyun Lee; Lisette Meijer; Thibaut Naninck; Lara A Doyle-Meyers; Alexander G White; H Jacob Borish; Amy L Hartman; Xavier Alvarez; Shashank Ganatra; Deepak Kaushal; Rudolf P Bohm; Roger le Grand; Charles A Scanga; Jan A M Langermans; Ronald E Bontrop; Courtney L Finch; JoAnne L Flynn; Claudia Calcagno; Ian Crozier; Jens H Kuhn
Journal:  Trends Mol Med       Date:  2021-12-07       Impact factor: 15.272

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.